Edward Tobinick

Edward Tobinick
Edward Tobinick
Born	New York City, US
Nationality	American
Alma mater	Brandeis University (B.S. Biology, 1973); UC San Diego School of Medicine (M.D., 1977)
Occupation	Physician
Known for	Perispinal Etanercept
Website	http://www.nrimed.com

Edward Tobinick M.D. is an American physician, inventor, and scientist, who invented the use of the drug etanercept for chronic neurological dysfunction after stroke and brain injury,[1][2] with multiple issued U.S. and foreign patents, including U.S. patent 8,900,583.

On October 6, 2018, Greg Hunt MP, the Minister for Health (Australia), announced that his government was allocating funds specifically for the study of perispinal etanercept for the rehabilitation of stroke survivors in Australia.[3][4]

Selected publications

Year	Article	Journal / Textbook
2010	Edward Tobinick, Perispinal Etanercept: A New Therapeutic Paradigm in Neurology.	Expert Review of Neurotherapeutics 2010 Jun;10(6):985-1002.
2011	Edward Tobinick, Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases.	CNS Drugs 2011, 25(2): p. 145-55.
2012	Tobinick, E., N.M. Kim, G. Reyzin, H. Rodriguez-Romanacce, and V. DePuy, Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept.	CNS Drugs 2012, 26(12): p. 1051–70.
2014	Ignatowski, T.A., R.N. Spengler, K.M. Dhandapani, H. Folkersma, R.F. Butterworth, and E. Tobinick, Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.	CNS Drugs 2014, 25(2): p. 145-55.
2014	Tobinick, E., H. Rodriguez-Romanacce, A. Levine, T.A. Ignatowski, and R.N. Spengler, Immediate neurological recovery following perispinal etanercept years after brain injury.	Clin Drug Investig 2014, 34(5): p. 361-6.
2016	Edward Tobinick, Perispinal Delivery of CNS Drugs.	CNS Drugs 2016 Jun;30(6):469-80.
2017	Tobinick, E., H. Rodriguez-Romanacce, R. Kinssies, and N.M. Kim, Chapter 7 - Perispinal Etanercept for Traumatic Brain Injury.	New Therapeutics for Traumatic Brain Injury, K.A. Heidenreich, Editor. 2017, Academic Press/Elsevier: New York.
2018	Edward Tobinick, Perispinal etanercept advances as a neurotherapeutic.	Expert Review of Neurotherapeutics 2018, 18(6): p. 453-455.

References

Singh, Anita (February 7, 2017). "Andrew Marr: how having a stroke changed my marriage for the better". The Telegraph. Retrieved November 17, 2018.
"New hope for survivors of stroke and traumatic brain injury". Springer Select. October 31, 2012. Retrieved November 17, 2018.
"Stroke drug trial set for Australia". SBS News. October 6, 2018. Retrieved November 17, 2018.
Hunt MP, Greg (October 6, 2018). "$1 million to support the rehabilitation of stroke survivors". Australia Ministry of Health. Retrieved November 17, 2018.

Selected patents

Year Issued	Inventor	Title	Country
2009	Edward Tobinick	Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers. U.S. Patent 7,629,311”	US
2014	Edward Tobinick	Methods for treatment of brain injury using biologics. U.S. Patent 8,900,583	US

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] Singh, Anita (February 7, 2017). "Andrew Marr: how having a stroke changed my marriage for the better". The Telegraph. Retrieved November 17, 2018.

[2] "New hope for survivors of stroke and traumatic brain injury". Springer Select. October 31, 2012. Retrieved November 17, 2018.

[3] "Stroke drug trial set for Australia". SBS News. October 6, 2018. Retrieved November 17, 2018.

[4] Hunt MP, Greg (October 6, 2018). "$1 million to support the rehabilitation of stroke survivors". Australia Ministry of Health. Retrieved November 17, 2018.